Rabies in a postpandemic world: resilient reservoirs, redoubtable riposte, recurrent roadblocks, and resolute recidivism.

动物疾病(英文) Pub Date : 2023-01-01 Epub Date: 2023-05-19 DOI:10.1186/s44149-023-00078-8
Charles E Rupprecht, Philip P Mshelbwala, R Guy Reeves, Ivan V Kuzmin
{"title":"Rabies in a postpandemic world: resilient reservoirs, redoubtable riposte, recurrent roadblocks, and resolute recidivism.","authors":"Charles E Rupprecht,&nbsp;Philip P Mshelbwala,&nbsp;R Guy Reeves,&nbsp;Ivan V Kuzmin","doi":"10.1186/s44149-023-00078-8","DOIUrl":null,"url":null,"abstract":"<p><p>Rabies is an ancient disease. Two centuries since Pasteur, fundamental progress occurred in virology, vaccinology, and diagnostics-and an understanding of pathobiology and epizootiology of rabies in testament to One Health-before common terminological coinage. Prevention, control, selective elimination, and even the unthinkable-occasional treatment-of this zoonosis dawned by the twenty-first century. However, in contrast to smallpox and rinderpest, eradication is a wishful misnomer applied to rabies, particularly post-COVID-19 pandemic. Reasons are minion. Polyhostality encompasses bats and mesocarnivores, but other mammals represent a diverse spectrum of potential hosts. While rabies virus is the classical member of the genus, other species of lyssaviruses also cause the disease. Some reservoirs remain cryptic. Although global, this viral encephalitis is untreatable and often ignored. As with other neglected diseases, laboratory-based surveillance falls short of the notifiable ideal, especially in lower- and middle-income countries. Calculation of actual burden defaults to a flux within broad health economic models. Competing priorities, lack of defined, long-term international donors, and shrinking local champions challenge human prophylaxis and mass dog vaccination toward targets of 2030 for even canine rabies impacts. For prevention, all licensed vaccines are delivered to the individual, whether parenteral or oral-essentially 'one and done'. Exploiting mammalian social behaviors, future 'spreadable vaccines' might increase the proportion of immunized hosts per unit effort. However, the release of replication-competent, genetically modified organisms selectively engineered to spread intentionally throughout a population raises significant biological, ethical, and regulatory issues in need of broader, transdisciplinary discourse. How this rather curious idea will evolve toward actual unconventional prevention, control, or elimination in the near term remains debatable. In the interim, more precise terminology and realistic expectations serve as the norm for diverse, collective constituents to maintain progress in the field.</p>","PeriodicalId":69105,"journal":{"name":"动物疾病(英文)","volume":"3 1","pages":"15"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195671/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"动物疾病(英文)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s44149-023-00078-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Rabies is an ancient disease. Two centuries since Pasteur, fundamental progress occurred in virology, vaccinology, and diagnostics-and an understanding of pathobiology and epizootiology of rabies in testament to One Health-before common terminological coinage. Prevention, control, selective elimination, and even the unthinkable-occasional treatment-of this zoonosis dawned by the twenty-first century. However, in contrast to smallpox and rinderpest, eradication is a wishful misnomer applied to rabies, particularly post-COVID-19 pandemic. Reasons are minion. Polyhostality encompasses bats and mesocarnivores, but other mammals represent a diverse spectrum of potential hosts. While rabies virus is the classical member of the genus, other species of lyssaviruses also cause the disease. Some reservoirs remain cryptic. Although global, this viral encephalitis is untreatable and often ignored. As with other neglected diseases, laboratory-based surveillance falls short of the notifiable ideal, especially in lower- and middle-income countries. Calculation of actual burden defaults to a flux within broad health economic models. Competing priorities, lack of defined, long-term international donors, and shrinking local champions challenge human prophylaxis and mass dog vaccination toward targets of 2030 for even canine rabies impacts. For prevention, all licensed vaccines are delivered to the individual, whether parenteral or oral-essentially 'one and done'. Exploiting mammalian social behaviors, future 'spreadable vaccines' might increase the proportion of immunized hosts per unit effort. However, the release of replication-competent, genetically modified organisms selectively engineered to spread intentionally throughout a population raises significant biological, ethical, and regulatory issues in need of broader, transdisciplinary discourse. How this rather curious idea will evolve toward actual unconventional prevention, control, or elimination in the near term remains debatable. In the interim, more precise terminology and realistic expectations serve as the norm for diverse, collective constituents to maintain progress in the field.

Abstract Image

Abstract Image

Abstract Image

疫情后世界的狂犬病:有韧性的水库、令人敬畏的反击、反复出现的路障和坚决的累犯。
狂犬病是一种古老的疾病。巴斯德问世两个世纪以来,病毒学、疫苗学和诊断学取得了根本性进展,对狂犬病的病理生物学和流行动物学也有了了解,这证明了在通用术语出现之前的“一个健康”。这种人畜共患疾病的预防、控制、选择性消除,甚至是难以想象的偶尔治疗,在21世纪开始出现。然而,与天花和牛瘟相比,根除狂犬病是一厢情愿的误称,尤其是在新冠肺炎大流行后。理由是卑鄙的。多宿主包括蝙蝠和中食肉动物,但其他哺乳动物代表了多种潜在宿主。狂犬病病毒是该属的经典成员,其他种类的赖沙病毒也会引起这种疾病。一些储层仍然是隐蔽的。尽管这种病毒性脑炎是全球性的,但它是无法治疗的,而且经常被忽视。与其他被忽视的疾病一样,基于实验室的监测没有达到应报告的理想,尤其是在中低收入国家。实际负担的计算默认为广义健康经济模型中的通量。相互竞争的优先事项、缺乏明确的长期国际捐助者以及地方冠军的减少,都对人类预防和大规模犬类疫苗接种提出了挑战,使其无法实现2030年甚至犬类狂犬病影响的目标。为了预防,所有获得许可的疫苗都是提供给个人的,无论是肠外还是口服,基本上都是“一次性”的。利用哺乳动物的社会行为,未来的“可传播疫苗”可能会增加每单位努力免疫宿主的比例。然而,有选择性地将具有复制能力的转基因生物释放出来,使其在人群中有意传播,这引发了重大的生物学、伦理和监管问题,需要更广泛的跨学科讨论。这个相当奇怪的想法将如何在短期内演变为实际的非常规预防、控制或消除仍有争议。在此期间,更精确的术语和现实的期望成为多样化的集体成员保持该领域进展的规范。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信